PatientsVille.com Logo


Ginkgo Medical Research Studies

Up-to-date List of Ginkgo Medical Research Studies

What Research is Being Done?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. Following list includes both interventional and observational studies.

Latest Ginkgo Medical Research Studies

Rank Status Study
1 Not yet recruiting Comparison of the Panax Ginseng + Associations to Ginkgo Biloba in the Treatment of Cognitive Function Disorders
Condition: Memory Deficit
Interventions: Drug: Panax Ginseng + Ginkgo Biloba + Polyminerals + Multivitamin;   Drug: Ginkgo Biloba (Tebonin®)
Outcome Measure: Study to evaluate the efficacy and safety of the association Panax Ginseng + Ginkgo Biloba + Polyminerals + Multivitamins compared to Ginkgo Biloba (Tebonin ®) for the symptomatic treatment of disorders of cognitive function.
2 Unknown  Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
Conditions: Mild Cognitive Impairment;   Cerebrovascular Insufficiency
Interventions: Drug: Ginkgo biloba standardized extract 24/6;   Drug: Ginkgo Biloba standardized extract 24/6;   Drug: placebo
Outcome Measures: Changes of MDRS;   Changes of VFT;   Changes of CGI;   Changes of SCAG;   Changes of MMSE;   Changes of TCD, and color Doppler of carotid arteries;   Changes of platelets, hematocrit, prothrombin time, and activated partial tromboplastin time;   Changes of total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides;   Safety will be assessed according to occurrence of adverse events during the trial
3 Unknown  Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Dietary Supplement: GINGKO BILOBA
Outcome Measures: Repigmentation (more than 50% from baseline) as the primary outcome;   Quality-of-life - as secondary outcome .
4 Not yet recruiting Clopidogrel Resistance and Embolism in Carotid Artery Stenting
Condition: Carotid Stenosis
Interventions: Drug: Ticlopidine + Ginko biloba;   Drug: Clopidogrel
Outcome Measures: New ischemic lesion on diffusion-weighted imaging (DWI);   Number and Volume of new ischemic lesions on DWI;   Benign and malignant microembolic signals (MES) on transcranial Doppler (TCD);   Ischemic stroke or transient ischemic attack (TIA);   Change of clopidogrel resistance;   Pucture site hematoma;   Mycocardial infarction;   Death;   Hematological abnormalities
5 Unknown  Efficacy and Safety Study of Combination of Ginkgo Extract and Ginseng Extract in Children With ADHD(Attention Deficit Hyperactivity Disorder)
Condition: Mental Disorders
Interventions: Drug: YY-162;   Drug: Placebo
Outcome Measures: Korea-ADHD Rating scale;   IOWA conner's rating scale;   Clinical Global Impression(Severity and Improvement);   Advanced Test of Attention;   children's color trails test and stroop test;   Intelligence test(from KEDI-WISC)
6 Recruiting The Efficacy of Steroid Therapy in Vestibular Neuritis
Condition: Vestibular Neuritis
Interventions: Drug: Ginkgo biloba & Methylprednisolone;   Drug: Ginkgo biloba
Outcome Measures: The improvement in vestibular function test (caloric & videop HIT) after treatment;   The improvement in dizziness handicap inventory after treatment
7 Not yet recruiting Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
Condition: Tinnitus
Interventions: Drug: Ginkgo biloba;   Behavioral: modified tinnitus retraining therapy (TRT)
Outcome Measure: Tinnitus Handicap Inventory (THI)
8 Unknown  Treatment of Depression in Parkinson's Disease
Condition: Depression in Parkinson's Disease
Interventions: Drug: Xiaoyao Pill;   Drug: Bupleurum+Ginkgo;   Drug: placebo
Outcome Measures: Hamilton Depression Scale;   the responder rate (defined as score reduction of HAMD-17>=50%);   the Geriatric Depression Scale
9 Unknown  Treatment of Dry Eye With Supplements
Condition: Dry Eye Syndromes
Intervention: Dietary Supplement: Vitamac® Tag and Nacht capsules
Outcome Measures: Improvement of subjective symptoms of dry eye syndrome;   Break up time (BUT);   Visual Acuity;   Tear film osmolarity;   OSI (Objective Scattering Index);   Schirmer I test;   Staining of the cornea with fluorescein;   Impression cytology;   Tear cytokines/chemokines;   Data from patient diary how often Hylo-Comod® eye drops were used
10 Recruiting Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy
Condition: Recurrent Vestibulopathy
Interventions: Drug: Renexin (cilostazol 100mg + gingko biloba extract 80 mg);   Drug: Placebo
Outcome Measures: equilibrium score of dynamic posturography;   dizziness handicap inventory;   visual analogue scale (VAS) of vertigo;   Questionnaire for Quality of life (SF36)
11 Unknown  Comparative Effectiveness of Neuroprotectants on Acute Ischemic Stroke
Condition: Acute Ischemic Stroke
Outcome Measures: Effectiveness Outcome Measures;   Safety Outcome Measures;   Cost-effectiveness Outcome Measures
12 Recruiting The Effects of an Antioxidant Formulation on Ocular Blood Flow
Condition: Primary Open Angle Glaucoma
Interventions: Dietary Supplement: dietary supplement with antioxidants;   Dietary Supplement: Placebo
Outcome Measures: retinal capillary blood flow;   Retrobulbar blood flow velocities and vascular resistance;   Ocular perfusion pressure;   Ocular pulse amplitude

These studies may lead to new treatments and are adding insight into Ginkgo etiology and treatment.

A major focus of Ginkgo research is the development of new drugs and other treatment options. Studies seek to identify new drugs to treat various related disorders and to find safer, more effective doses for medications already being used. Other research is aimed at identifying receptors or drug targets.

Discuss Ginkgo